Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Cell Metabolism
|
December 14, 2011
Species differences in the effects of bezafibrate as a potential treatment of mitochondrial disorders
Fatima Djouadi, Jean Bastin
Nutrients
|
May 3, 2016
Resveratrol and Myopathy
Jean Bastin, Fatima Djouadi
Medecine Sciences : M/S
|
October 19, 2019
[Dysfunctions of mitochondrial fatty acid β-oxidation in rare and common diseases]
Jean Bastin, Fatima Djouadi
Medecine Sciences : M/S
|
June 29, 2022
[How dietary interventions can change lipid metabolism to affect tumor growth]
Jean Bastin, Fatima Djouadi
Cells
|
March 31, 2019
Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies
Fatima Djouadi, Jean Bastin
Journal of the American Society of Nephrology : JASN
|
May 25, 2001
PPARalpha gene expression in the developing rat kidney: role of glucocorticoids
Fatima Djouadi, Jean Bastin
Medecine Sciences : M/S
|
December 20, 2021
[Methylmalonic acid: A new link between ageing and tumour progression]
Fatima Djouadi, Sophie Mouillet-Richard
American Journal of Physiology. Renal Physiology
|
July 12, 2002
Effects of fatty acids on mitochondrial beta-oxidation enzyme gene expression in renal cell lines
Fetta Ouali, Fatima Djouadi, Jean Bastin
Human Molecular Genetics
|
March 8, 2011
Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts
Jean Bastin, Alexandra Lopes-Costa, Fatima Djouadi
The Journal of Clinical Endocrinology and Metabolism
|
December 23, 2004
Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells
Fatima Djouadi, Flore Aubey, Dimitri Schlemmer, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Cell Metabolism
|
December 14, 2011
Species differences in the effects of bezafibrate as a potential treatment of mitochondrial disorders
Fatima Djouadi, Jean Bastin
Nutrients
|
May 3, 2016
Resveratrol and Myopathy
Jean Bastin, Fatima Djouadi
Medecine Sciences : M/S
|
October 19, 2019
[Dysfunctions of mitochondrial fatty acid β-oxidation in rare and common diseases]
Jean Bastin, Fatima Djouadi
Medecine Sciences : M/S
|
June 29, 2022
[How dietary interventions can change lipid metabolism to affect tumor growth]
Jean Bastin, Fatima Djouadi
Cells
|
March 31, 2019
Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies
Fatima Djouadi, Jean Bastin
Journal of the American Society of Nephrology : JASN
|
May 25, 2001
PPARalpha gene expression in the developing rat kidney: role of glucocorticoids
Fatima Djouadi, Jean Bastin
Medecine Sciences : M/S
|
December 20, 2021
[Methylmalonic acid: A new link between ageing and tumour progression]
Fatima Djouadi, Sophie Mouillet-Richard
American Journal of Physiology. Renal Physiology
|
July 12, 2002
Effects of fatty acids on mitochondrial beta-oxidation enzyme gene expression in renal cell lines
Fetta Ouali, Fatima Djouadi, Jean Bastin
Human Molecular Genetics
|
March 8, 2011
Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts
Jean Bastin, Alexandra Lopes-Costa, Fatima Djouadi
The Journal of Clinical Endocrinology and Metabolism
|
December 23, 2004
Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells
Fatima Djouadi, Flore Aubey, Dimitri Schlemmer, et al.
Page
of 5